Alyeska Investment Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-218,837
| Closed | -$3.93M | – | 827 |
|
|
2021
Q2 | $3.93M | Sell |
218,837
-412,373
| -65% | -$7.4M | 0.05% | 389 |
|
|
2021
Q1 | $9.77M | Sell |
631,210
-615,363
| -49% | -$9.53M | 0.13% | 200 |
|
|
2020
Q4 | $15.2M | Buy |
1,246,573
+314,392
| +34% | +$3.84M | 0.21% | 143 |
|
|
2020
Q3 | $12M | Buy |
932,181
+228,977
| +33% | +$2.94M | 0.18% | 162 |
|
|
2020
Q2 | $7.15M | Buy |
703,204
+139,424
| +25% | +$1.42M | 0.11% | 224 |
|
|
2020
Q1 | $4.58M | Buy |
563,780
+13,277
| +2% | +$108K | 0.09% | 194 |
|
|
2019
Q4 | $4.76M | Buy |
550,503
+274,365
| +99% | +$2.37M | 0.06% | 225 |
|
|
2019
Q3 | $1.7M | Buy |
276,138
+25,659
| +10% | +$158K | 0.02% | 275 |
|
|
2019
Q2 | $4.16M | Buy |
+250,479
| New | +$4.16M | 0.05% | 243 |
|